Multi-centered Double Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Memantine at 20 mg BID in Patients With ALS Currently Taking Riluzole
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 15 May 2017
At a glance
- Drugs Memantine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms TAME
- 07 Jun 2017 Biomarkers information updated
- 23 Jan 2017 Planned initiation date changed from 1 Jul 2016 to 1 Jul 2017.
- 26 Apr 2016 Planned initiation date changed from 1 Apr 2016 to 1 Jul 2016.